• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    RLX Technology Announces Unaudited Third Quarter 2024 Financial Results

    11/15/24 4:30:00 AM ET
    $RLX
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $RLX alert in real time by email

    SHENZHEN, China, Nov. 15, 2024 /PRNEWSWIRE/ - RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced its unaudited financial results for the third quarter ended September 30, 2024.

    Third Quarter 2024 Financial Highlights

    • Net revenues were RMB756.3 million (US$107.8 million) in the third quarter of 2024, compared with RMB498.9 million in the same period of 2023.
    • Gross margin was 27.2% in the third quarter of 2024, compared with 24.1% in the same period of 2023.
    • U.S. GAAP net income was RMB169.4 million (US$24.1 million) in the third quarter of 2024, compared with RMB176.6 million in the same period of 2023.
    • Non-GAAP net income[1] was RMB261.9 million (US$37.3 million) in the third quarter of 2024, compared with RMB201.4 million in the same period of 2023.

    "We delivered another strong performance in the third quarter of 2024, showcasing our ability to consistently excel in diverse markets despite rapidly evolving trends and regulations," commented Ms. Ying (Kate) Wang, Co-founder, Chairperson of the Board of Directors, and Chief Executive Officer of RLX Technology. "Our efficient, adaptable localization strategies have empowered us to establish market leadership in multiple countries by cultivating strong product-market alignment and building solid relationships with local distributors and retailers. Furthermore, our broad offering of premium, reliable cartridge-based products and growing selection of disposables and open-system products have earned the loyalty of adult smokers worldwide. As a trusted e-vapor brand for adult smokers, we remain committed to creating innovative, high-quality products in line with shifting trends and regulations, meeting users' needs while driving RLX's long-term growth."

    Mr. Chao Lu, Chief Financial Officer of RLX Technology, added, "Our robust third quarter results were led by a 51.6% year-over-year increase in net revenues to RMB756.3 million, underscoring the success of our internationalization efforts. Our gross margin also improved year over year, expanding 3.1 percentage points to 27.2%, thanks to a favorable shift in our revenue mix and our effective cost optimization initiatives. Notably, we maintained stable non-GAAP operating expenses while rapidly growing revenue, highlighting our operational leverage. We are also excited to continue returning value to our shareholders with our second cash dividend since our IPO while also executing our share repurchase program. Going forward, we will remain dedicated to pursuing development opportunities that deliver sustainable, growing profits and enhance returns for our shareholders."

    Third Quarter 2024 Financial Results

    Net revenues were RMB756.3 million (US$107.8 million) in the third quarter of 2024, compared with RMB498.9 million in the same period of 2023. The increase was primarily due to our international expansion.

    Gross profit was RMB206.0 million (US$29.4 million) in the third quarter of 2024, compared with RMB120.0 million in the same period of 2023.

    Gross margin was 27.2% in the third quarter of 2024, compared with 24.1% in the same period of 2023. The increase was primarily due to a favorable change in the revenue mix and the cost optimization efforts.

    Operating expenses were RMB216.6 million (US$30.9 million) in the third quarter of 2024, compared with RMB154.4 million in the same period of 2023. The increase was primarily due to the fluctuation of share-based compensation expenses, from RMB24.8 million in the third quarter of 2023 to RMB92.5 million (US$13.2 million) in the third quarter of 2024. The changes in share-based compensation expenses were primarily due to the changes in the fair value of the share incentive awards that the Company granted to its employees in line with the fluctuations in the Company's share price.

    Selling expenses were RMB69.0 million (US$9.8 million) in the third quarter of 2024, compared with RMB44.8 million in the same period of 2023, primarily due to an increase in share-based compensation expenses and branding expenses.

    General and administrative expenses were RMB123.2 million (US$17.6 million) in the third quarter of 2024, compared with RMB78.8 million in the same period of 2023, primarily due to an increase in share-based compensation expenses.

    Research and development expenses were RMB24.4 million (US$3.5 million) in the third quarter of 2024, compared with RMB30.8 million in the same period of 2023, primarily due to a decrease in salaries, welfare benefits and depreciation and amortization expenses, slightly offset by an increase in share-based compensation expenses.

    Loss from operations was RMB10.7 million (US$1.5 million) in the third quarter of 2024, compared with RMB34.3 million in the same period of 2023.

    Income tax expense was RMB30.4 million (US$4.3 million) in the third quarter of 2024, compared with RMB1.7 million in the same period of 2023.

    U.S. GAAP net income was RMB169.4 million (US$24.1 million) in the third quarter of 2024, compared with RMB176.6 million in the same period of 2023.

    Non-GAAP net income was RMB261.9 million (US$37.3 million) in the third quarter of 2024, compared with RMB201.4 million in the same period of 2023.

    U.S. GAAP basic and diluted net income per American depositary share ("ADS") were RMB0.135 (US$0.019) and RMB0.129 (US$0.018), respectively, in the third quarter of 2024, compared with U.S. GAAP basic and diluted net income per ADS of RMB0.133 and RMB0.130, respectively, in the same period of 2023.

    Non-GAAP basic and diluted net income per ADS[2] were RMB0.211 (US$0.030) and RMB0.200 (US$0.029), respectively, in the third quarter of 2024, compared with non-GAAP basic and diluted net income per ADS of RMB0.152 and RMB0.149, respectively, in the same period of 2023.

    Balance Sheet and Cash Flow

    As of September 30, 2024, the Company had cash and cash equivalents, restricted cash, short-term bank deposits, net, short-term investments, net, long-term bank deposits, net and long-term investment securities, net of RMB15,361.7 million (US$2,189.0 million), compared with RMB14,930.8 million as of June 30, 2024. In the third quarter of 2024, net cash generated from operating activities was RMB156.6 million (US$22.3 million).

    Dividend Payment

    The Company announced that its Board of Directors approved a cash dividend of US$0.01 per ordinary share, or US$0.01 per ADS, to holders of ordinary shares and holders of ADSs, respectively, as of the close of business on December 6, 2024 Beijing/Hong Kong Time and New York Time, respectively, payable in U.S. dollars. The payment date is expected to be on or around December 13, 2024 and on or around December 20, 2024 for holders of ordinary shares and holders of ADSs, respectively.

    Conference Call

    The Company's management will host an earnings conference call at 7:00 AM U.S. Eastern Time on November 15, 2024 (8:00 PM Beijing/Hong Kong Time on November 15, 2024).

    Dial-in details for the earnings conference call are as follows:

    United States (toll-free):

    +1-888-317-6003

    International:

    +1-412-317-6061

    Hong Kong, China (toll-free):

    +800-963-976

    Hong Kong, China:

    +852-5808-1995

    Mainland China:

    400-120-6115

    Participant Code:

    6222824

    Participants should dial in 10 minutes before the scheduled start time and ask to be connected to the call for "RLX Technology Inc." with the Participant Code as set forth above.

    Additionally, a live and archived webcast of the conference call will be available on the Company's investor relations website at https://ir.relxtech.com.

    A replay of the conference call will be accessible approximately two hours after the conclusion of the call until November 22, 2024, by dialing the following telephone numbers:

    United States:

    +1-877-344-7529

    International:

    +1-412-317-0088

    Replay Access Code:

    7489030

     

    [1] Non-GAAP net income is a non-GAAP financial measure. For more information on the Company's non-GAAP financial measures, please see the section "Non-GAAP Financial Measures" and the table captioned "Unaudited Reconciliation of GAAP and Non-GAAP Results" set forth at the end of this press release.

    [2] Non-GAAP basic and diluted net income per ADS is a non-GAAP financial measure. For more information on the Company's non-GAAP financial measures, please see the section "Non-GAAP Financial Measures" and the table captioned "Unaudited Reconciliation of GAAP and Non-GAAP Results" set forth at the end of this press release.

    About RLX Technology Inc.

    RLX Technology Inc. (NYSE:RLX) is a leading global branded e-vapor company. The Company leverages its strong in-house technology, product development capabilities and in-depth insights into adult smokers' needs to develop superior e-vapor products.

    For more information, please visit: http://ir.relxtech.com.

    Non-GAAP Financial Measures

    The Company uses non-GAAP net income and non-GAAP basic and diluted net income per ADS, each a non-GAAP financial measure, in evaluating its operating results and for financial and operational decision-making purposes. Non-GAAP net income represents net income excluding share-based compensation expenses. Non-GAAP basic and diluted net income per ADS is computed using non-GAAP net income attributable to RLX Technology Inc. and the same number of ADSs used in U.S. GAAP basic and diluted net income per ADS calculation.

    The Company presents these non-GAAP financial measures because they are used by the management to evaluate its operating performance and formulate business plans. The Company believes that they help identify underlying trends in its business that could otherwise be distorted by the effect of certain expenses that are included in net income. The Company also believes that the use of the non-GAAP measures facilitates investors' assessment of its operating performance, as they could provide useful information about its operating results, enhances the overall understanding of its past performance and future prospects and allows for greater visibility with respect to key metrics used by the management in its financial and operational decision making.

    The non-GAAP financial measures are not defined under U.S. GAAP and are not presented in accordance with U.S. GAAP. The non-GAAP financial measures have limitations as analytical tools. They should not be considered in isolation or construed as an alternative to net income, basic and diluted net income per ADS or any other measure of performance or as an indicator of its operating performance. Investors are encouraged to review its historical non-GAAP financial measures to the most directly comparable U.S. GAAP measures. The non-GAAP financial measures here may not be comparable to similarly titled measures presented by other companies. Other companies may calculate similarly titled measures differently, limiting their usefulness as comparative measures to our data. The Company encourages investors and others to review its financial information in its entirety and not rely on any single financial measure.

    For more information on the non-GAAP financial measures, please see the table captioned "Unaudited Reconciliation of GAAP and non-GAAP Results" set forth at the end of this press release.

    Exchange Rate Information

    This announcement contains translations of certain RMB amounts into U.S. dollars at a specified rate solely for the convenience of the reader. Unless otherwise noted, all translations from RMB to U.S. dollars and from U.S. dollars to RMB are made at a rate of RMB7.0176 to US$1.00, the exchange rate on September 30, 2024, set forth in the H.10 statistical release of the Federal Reserve Board. The Company makes no representation that the RMB or U.S. dollar amounts referred could be converted into U.S. dollars or RMB, as the case may be, at any particular rate or at all.

    Safe Harbor Statement

    This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "is/are likely to," "potential," "continue" and similar statements. Among other things, quotations from management in this announcement, as well as the Company's strategic and operational plans, contain forward- looking statements. The Company may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including but not limited to statements about the Company's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company's growth strategies; its future business development, results of operations and financial condition; trends and competition in global e-vapor market; changes in its revenues and certain cost or expense items; governmental policies, laws and regulations across various jurisdictions relating to the Company's industry, and general economic and business conditions globally and in China and assumptions underlying or related to any of the foregoing. Further information regarding these risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. All information provided in this press release and in the attachments is current as of the date of this press release, and the Company does not undertake any obligation to update such information, except as required under applicable law.

    For more information, please contact:

    In China:

    RLX Technology Inc.

    Head of Capital Markets

    Sam Tsang

    Email: [email protected]

    Piacente Financial Communications

    Jenny Cai

    Tel: +86-10-6508-0677

    Email: [email protected] 

    In the United States:

    Piacente Financial Communications

    Brandi Piacente

    Tel: +1-212-481-2050

    Email: [email protected]

     

     

     

    RLX TECHNOLOGY INC.

    UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

    (All amounts in thousands)











    As of



    December 31,

    September 30,

    September 30,



    2023

    2024

    2024



    RMB

    RMB

    US$

    ASSETS







    Current assets:







    Cash and cash equivalents

    2,390,298

    3,255,500

    463,905

    Restricted cash

    29,760

    58,265

    8,303

    Short-term bank deposits, net

    2,631,256

    2,602,887

    370,908

    Receivables from online payment platforms

    6,893

    5,357

    763

    Short-term investments

    3,093,133

    2,199,658

    313,449

    Accounts and notes receivable, net

    60,482

    121,939

    17,376

    Inventories

    144,850

    81,432

    11,604

    Amounts due from related parties

    118,736

    248,762

    35,448

    Prepayments and other current assets, net

    508,435

    299,409

    42,666

    Total current assets

    8,983,843

    8,873,209

    1,264,422

    Non-current assets:







    Property, equipment and leasehold improvement, net

    77,358

    56,998

    8,122

    Intangible assets, net

    69,778

    59,156

    8,430

    Long-term investments, net

    8,000

    8,000

    1,140

    Deferred tax assets, net

    58,263

    58,262

    8,302

    Right-of-use assets, net

    52,562

    31,304

    4,461

    Long-term bank deposits, net

    1,757,804

    1,022,279

    145,674

    Long-term investment securities, net

    5,236,109

    6,223,159

    886,791

    Goodwill

    66,506

    64,528

    9,195

    Other non-current assets, net

    4,874

    5,632

    803

    Total non-current assets

    7,331,254

    7,529,318

    1,072,918

    Total assets

    16,315,097

    16,402,527

    2,337,340









    LIABILITIES AND SHAREHOLDERS' EQUITY







    Current liabilities:







    Accounts and notes payable

    266,426

    352,403

    50,217

    Contract liabilities

    49,586

    24,508

    3,492

    Salary and welfare benefits payable

    39,256

    75,047

    10,694

    Taxes payable

    77,164

    127,526

    18,172

    Accrued expenses and other current liabilities

    103,996

    107,771

    15,357

    Amounts due to related parties

    101,927

    10,380

    1,479

    Dividend payable

    881

    -

    -

    Lease liabilities - current portion

    29,435

    16,710

    2,381

    Total current liabilities

    668,671

    714,345

    101,792









    Non-current liabilities:







    Deferred tax liabilities

    23,591

    21,757

    3,100

    Lease liabilities - non-current portion

    24,419

    7,136

    1,017

    Total non-current liabilities

    48,010

    28,893

    4,117

    Total liabilities

    716,681

    743,238

    105,909

















    Shareholders' Equity:







    Total RLX Technology Inc. shareholders' equity

    15,609,393

    15,662,993

    2,231,959

    Noncontrolling interests

    (10,977)

    (3,704)

    (528)

    Total shareholders' equity

    15,598,416

    15,659,289

    2,231,431









    Total liabilities and shareholders' equity

    16,315,097

    16,402,527

    2,337,340

     

     

     

    RLX TECHNOLOGY INC.

    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME/(LOSS)

    (All amounts in thousands, except for share and per share data)





















    For the three months ended



    For the nine months ended



    September 30,

    June 30,

    September 30,

    September 30,



    September 30,

    September 30,

    September 30,



    2023

    (As adjusted) (a)

    2024

    2024

    2024



    2023

    (As adjusted) (a)

    2024

    2024



    RMB

    RMB

    RMB

    US$



    RMB

    RMB

    US$



















    Net revenues

    498,929

    627,176

    756,288

    107,770



    1,065,929

    1,935,087

    275,748

    Cost of revenues

    (278,578)

    (400,712)

    (473,379)

    (67,456)



    (529,004)

    (1,201,701)

    (171,241)

    Excise tax on products

    (100,313)

    (68,602)

    (76,933)

    (10,963)



    (272,624)

    (226,775)

    (32,315)

    Gross profit

    120,038

    157,862

    205,976

    29,351



    264,301

    506,611

    72,192



















    Operating expenses:

















    Selling expenses

    (44,751)

    (62,235)

    (68,975)

    (9,829)



    (175,738)

    (184,097)

    (26,234)

    General and administrative expenses

    (78,849)

    (128,997)

    (123,226)

    (17,560)



    (293,985)

    (362,177)

    (51,610)

    Research and development expenses

    (30,783)

    40

    (24,435)

    (3,482)



    (150,782)

    (55,935)

    (7,971)

    Total operating expenses

    (154,383)

    (191,192)

    (216,636)

    (30,871)



    (620,505)

    (602,209)

    (85,815)



















    Loss from operations

    (34,345)

    (33,330)

    (10,660)

    (1,520)



    (356,204)

    (95,598)

    (13,623)



















    Other income:

















    Interest income, net

    158,260

    154,207

    156,659

    22,324



    469,951

    469,724

    66,935

    Investment income  

    21,028

    12,718

    13,070

    1,862



    63,001

    38,564

    5,495

    Others, net

    33,412

    22,739

    40,745

    5,806



    183,949

    92,427

    13,171

    Income before income tax

    178,355

    156,334

    199,814

    28,472



    360,697

    505,117

    71,978

    Income tax expense

    (1,746)

    (21,389)

    (30,423)

    (4,335)



    (35,677)

    (68,156)

    (9,712)

    Net income

    176,609

    134,945

    169,391

    24,137



    325,020

    436,961

    62,266

    Less: net income attributable to noncontrolling interests

    1,579

    2,631

    3,737

    532



    4,169

    7,085

    1,010

    Net income attributable to RLX Technology Inc.

    175,030

    132,314

    165,654

    23,605



    320,851

    429,876

    61,256

    Other comprehensive (loss)/income:

















    Foreign currency translation adjustments

    (83,978)

    44,174

    (181,148)

    (25,813)



    331,004

    (124,268)

    (17,708)

    Unrealized income on long-term investment securities

    3,508

    705

    5,292

    754



    11,920

    5,984

    853

    Total other comprehensive (loss)/income

    (80,470)

    44,879

    (175,856)

    (25,059)



    342,924

    (118,284)

    (16,855)

    Total comprehensive income/(loss)

    96,139

    179,824

    (6,465)

    (922)



    667,944

    318,677

    45,411

    Less: total comprehensive income attributable to noncontrolling

        interests

    1,579

    2,618

    3,730

    531



    4,169

    7,078

    1,010

    Total comprehensive income/(loss) attributable to RLX

        Technology Inc.

    94,560

    177,206

    (10,195)

    (1,453)



    663,775

    311,599

    44,401



















    Net income per ordinary share/ADS 

















     Basic

    0.133

    0.108

    0.135

    0.019



    0.244

    0.348

    0.050

     Diluted

    0.130

    0.103

    0.129

    0.018



    0.239

    0.333

    0.047



















    Weighted average number of ordinary shares/ADSs

















    Basic

    1,316,452,743

    1,228,869,526

    1,225,417,517

    1,225,417,517



    1,317,292,081

    1,234,501,619

    1,234,501,619

    Diluted

    1,344,359,144

    1,284,388,803

    1,287,927,444

    1,287,927,444



    1,344,018,578

    1,289,831,349

    1,289,831,349



    Note (a): The Company acquired various companies on December 13, 2023, which was accounted for as an under common control transaction in accordance with ASC 805-50. The Company retrospectively adjusted the above comparative unaudited condensed consolidated statements of comprehensive income/(loss) in the prior quarter and prior nine months period.

     

     

     

    RLX TECHNOLOGY INC.

    UNAUDITED RECONCILIATION OF GAAP AND NON-GAAP RESULTS

    (All amounts in thousands, except for share and per share data, or otherwise noted)













    For the three months ended



    For the nine months ended



    September 30,

    June 30,

    September 30,

    September 30,



    September 30,

    September 30,

    September 30,



    2023

    (As adjusted) (b)

    2024

    2024

    2024



    2023

    (As adjusted) (b)

    2024

    2024



    RMB

    RMB

    RMB

    US$



    RMB

    RMB

    US$

    Net income

    176,609

    134,945

    169,391

    24,137



    325,020

    436,961

    62,266

    Add: share-based compensation expenses

















           Selling expenses

    (4,045)

    9,172

    5,768

    822



    4,571

    19,543

    2,785

           General and administrative expenses

    29,771

    93,026

    85,295

    12,154



    140,190

    244,735

    34,874

           Research and development expenses

    (936)

    (24,074)

    1,446

    206



    1,490

    (18,747)

    (2,671)

    Non-GAAP net income

    201,399

    213,069

    261,900

    37,319



    471,271

    682,492

    97,254



















    Net income attributable to RLX Technology Inc.

    175,030

    132,314

    165,654

    23,605



    320,851

    429,876

    61,256

    Add: share-based compensation expenses

    24,790

    78,124

    92,509

    13,182



    146,251

    245,531

    34,988

    Non-GAAP net income attributable to RLX Technology Inc.

    199,820

    210,438

    258,163

    36,787



    467,102

    675,407

    96,244



















    Non-GAAP net income per ordinary share/ADS

















    - Basic

    0.152

    0.171

    0.211

    0.030



    0.355

    0.547

    0.078

    - Diluted

    0.149

    0.164

    0.200

    0.029



    0.348

    0.524

    0.075

    Weighted average number of ordinary shares/ADSs

















    - Basic

    1,316,452,743

    1,228,869,526

    1,225,417,517

    1,225,417,517



    1,317,292,081

    1,234,501,619

    1,234,501,619

    - Diluted

    1,344,359,144

    1,284,388,803

    1,287,927,444

    1,287,927,444



    1,344,018,578

    1,289,831,349

    1,289,831,349



    Note (b): The Company acquired various companies on December 13, 2023, which was accounted for as an under common control transaction in accordance with ASC 805-50. The Company retrospectively adjusted the above unaudited reconciliation of GAAP and Non-GAAP results in the prior quarter and prior nine months period.

     

     

     

    RLX TECHNOLOGY INC.



    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS



    (All amounts in thousands)

























    For the three months ended



    For the nine months ended





    September 30,

    June 30,

    September 30,

    September 30,



    September 30,

    September 30,

    September 30,





    2023

    (As adjusted) (c)

    2024

    2024

    2024



    2023

    (As adjusted) (c)

    2024

    2024





    RMB

    RMB

    RMB

    US$



    RMB

    RMB

    US$



    Net cash generated from/(used in) operating

        activities

    82,853

    196,764

    156,554

    22,309



    (106,494)

    357,338

    50,920



    Net cash generated from investing activities

    967,234

    557,132

    139,120

    19,824



    1,780,871

    1,116,917

    159,159



    Net cash used in financing activities

    (206,577)

    -

    (74,780)

    (10,656)



    (401,311)

    (547,665)

    (78,042)



    Effect of foreign exchange rate changes on cash,

        cash equivalents and restricted cash

    (5,918)

    10,032

    (45,818)

    (6,529)



    52,884

    (32,883)

    (4,685)



    Net increase in cash and cash equivalents and

        restricted cash

    837,592

    763,928

    175,076

    24,948



    1,325,950

    893,707

    127,352



    Cash, cash equivalents and restricted cash at

        the beginning of the period

    1,777,444

    2,374,761

    3,138,689

    447,260



    1,289,086

    2,420,058

    344,856



    Cash, cash equivalents and restricted cash at

        the end of the period

    2,615,036

    3,138,689

    3,313,765

    472,208



    2,615,036

    3,313,765

    472,208























    Note (c): The Company acquired various companies on December 13, 2023, which was accounted for as an under common control transaction in accordance with ASC 805-50. The Company retrospectively adjusted the above comparative unaudited condensed consolidated statements of cash flows in the prior quarter and prior nine months period.



     

    Cision View original content:https://www.prnewswire.com/news-releases/rlx-technology-announces-unaudited-third-quarter-2024-financial-results-302305299.html

    SOURCE RLX Technology Inc.

    Get the next $RLX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RLX

    DatePrice TargetRatingAnalyst
    3/17/2025$2.80 → $2.50Buy → Neutral
    Citigroup
    8/8/2023$2.60Buy
    UBS
    More analyst ratings

    $RLX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • RLX Technology downgraded by Citigroup with a new price target

      Citigroup downgraded RLX Technology from Buy to Neutral and set a new price target of $2.50 from $2.80 previously

      3/17/25 7:42:34 AM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care
    • UBS initiated coverage on RLX Technology with a new price target

      UBS initiated coverage of RLX Technology with a rating of Buy and set a new price target of $2.60

      8/8/23 9:12:45 AM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care

    $RLX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • RLX Technology to Report First Quarter 2025 Financial Results on May 16, 2025

      - Earnings Call Scheduled for 8:00 a.m. ET on May 16, 2025 - SHENZHEN, China, May 8, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2025, before the U.S. markets open on Friday, May 16, 2025. The Company's management will host an earnings conference call at 8:00 AM U.S. Eastern Time on May 16, 2025 (8:00 PM Beijing/Hong Kong Time on May 16, 2025). Dial-in details for the earnings conference call are as follows: United States (toll free): +1-888-317-6003 International: +1-412-317-6061 Hong Kong, China (to

      5/8/25 2:30:00 AM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care
    • RLX Technology Files 2024 Annual Report on Form 20-F

      SHENZHEN, China, April 17, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the U.S. Securities and Exchange Commission (the "SEC") on April 17, 2025. The annual report on Form 20-F can be accessed on the SEC's website at https://www.sec.gov and on the Company's investor relations website at https://ir.relxtech.com. The Company will provide a hard copy of its audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request. About RLX Technology Inc. RLX Techno

      4/17/25 8:00:00 PM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care
    • RLX Technology Announces Unaudited Fourth Quarter and Fiscal Year 2024 Financial Results

      SHENZHEN, China, March 14, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced its unaudited financial results for the fourth quarter and the fiscal year ended December 31, 2024. Fourth Quarter 2024 Financial Highlights Net revenues were RMB813.5 million (US$111.4 million) in the fourth quarter of 2024, compared with RMB520.5 million in the same period of 2023.Gross margin was 27.0% in the fourth quarter of 2024, compared with 23.7% in the same period of 2023.U.S. GAAP net income was RMB127.4 million (US$17.5 million) in the fourth quarter of 2024, compared with RMB216.0 million in the same period

      3/14/25 5:30:00 AM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care

    $RLX
    Financials

    Live finance-specific insights

    See more
    • RLX Technology to Report First Quarter 2025 Financial Results on May 16, 2025

      - Earnings Call Scheduled for 8:00 a.m. ET on May 16, 2025 - SHENZHEN, China, May 8, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2025, before the U.S. markets open on Friday, May 16, 2025. The Company's management will host an earnings conference call at 8:00 AM U.S. Eastern Time on May 16, 2025 (8:00 PM Beijing/Hong Kong Time on May 16, 2025). Dial-in details for the earnings conference call are as follows: United States (toll free): +1-888-317-6003 International: +1-412-317-6061 Hong Kong, China (to

      5/8/25 2:30:00 AM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care
    • RLX Technology Announces Unaudited Fourth Quarter and Fiscal Year 2024 Financial Results

      SHENZHEN, China, March 14, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced its unaudited financial results for the fourth quarter and the fiscal year ended December 31, 2024. Fourth Quarter 2024 Financial Highlights Net revenues were RMB813.5 million (US$111.4 million) in the fourth quarter of 2024, compared with RMB520.5 million in the same period of 2023.Gross margin was 27.0% in the fourth quarter of 2024, compared with 23.7% in the same period of 2023.U.S. GAAP net income was RMB127.4 million (US$17.5 million) in the fourth quarter of 2024, compared with RMB216.0 million in the same period

      3/14/25 5:30:00 AM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care
    • RLX Technology to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 14, 2025

      - Earnings Call Scheduled for 8:00 a.m. ET on March 14, 2025 - SHENZHEN, China, March 3, 2025 /PRNewswire/ -- RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE:RLX), a leading global branded e-vapor company, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024, before the U.S. markets open on Friday, March 14, 2025. The Company's management will host an earnings conference call at 8:00 AM U.S. Eastern Time on March 14, 2025 (8:00 PM Beijing/Hong Kong Time on March 14, 2025). Dial-in details for the earnings conference call are as follows: United States (toll free): +1-888-317-6003 International: +1-412

      3/3/25 10:30:00 PM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care

    $RLX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $RLX
    SEC Filings

    See more
    • SEC Form SC 13G/A filed by RLX Technology Inc. (Amendment)

      SC 13G/A - RLX Technology Inc. (0001828365) (Subject)

      2/7/24 6:06:29 AM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by RLX Technology Inc. (Amendment)

      SC 13G/A - RLX Technology Inc. (0001828365) (Subject)

      2/6/24 4:01:28 PM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by RLX Technology Inc. (Amendment)

      SC 13G/A - RLX Technology Inc. (0001828365) (Subject)

      2/14/23 6:01:42 AM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 20-F filed by RLX Technology Inc.

      20-F - RLX Technology Inc. (0001828365) (Filer)

      4/17/25 4:01:47 PM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 6-K filed by RLX Technology Inc.

      6-K - RLX Technology Inc. (0001828365) (Filer)

      3/14/25 6:10:16 AM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 6-K filed by RLX Technology Inc.

      6-K - RLX Technology Inc. (0001828365) (Filer)

      11/15/24 4:01:25 PM ET
      $RLX
      Medicinal Chemicals and Botanical Products
      Health Care